S. Hadidi

发表

Vanishing Lung Syndrome

S. Hadidi, Rupal Shastri, 2017, The Journal of the American Osteopathic Association.

Timing of Pregnancy and Survival in Women With Breast Cancer.

S. Hadidi, 2018 .

Melflufen in multiple myeloma: the conclusion matters.

S. Hadidi, 2022, The Lancet. Haematology.

High Dose (Conditioning) Regimens used prior to Autologous Stem Cell Transplantation in Multiple Myeloma.

S. Hadidi, Mohammad Ali, 2022, Transplantation and cellular therapy.

Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies.

H. Heslop, C. Ramos, R. Kamble, 2020 .

Analysis of repeated roles in editorial boards at oncology focused journals.

A. Goodman, G. R. Mohyuddin, N. Gagelmann, 2022, Journal of cancer policy.

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma

I. Nookaew, P. L. Bergsagel, Hongwei Xu, 2023, Cell reports. Medicine.

Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems

M. Zangari, F. van Rhee, S. Thanendrarajan, 2024, Blood cancer journal.

Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study.

R. Foley, G. R. Mohyuddin, Hyra Sapru, 2024, Clinical lymphoma, myeloma & leukemia.

Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.

M. Zangari, F. van Rhee, B. Dhakal, 2024, Bone marrow transplantation.